Jeremy M Adelstein, Parshva A Sanghvi, Kira Smith, Robert J Burkhart, Andrew J Moyal, Luc M Fortier, Bhargavi Maheshwer, Jacob G Calcei, James E Voos, Michael J Salata
{"title":"Increased Utilization of Hip Arthroscopy in the United States from 2015 to 2023 and Projected Growth through 2030.","authors":"Jeremy M Adelstein, Parshva A Sanghvi, Kira Smith, Robert J Burkhart, Andrew J Moyal, Luc M Fortier, Bhargavi Maheshwer, Jacob G Calcei, James E Voos, Michael J Salata","doi":"10.1016/j.arthro.2025.03.034","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to assess hip arthroscopy epidemiology in the United States (US) from 2015-2023 and provide projections through 2030, as well as analyze rates of postoperative complications.</p><p><strong>Methods: </strong>The TriNetX/U.S. Collaborative Networks database was utilized to identify patients aged 10-89 who underwent hip arthroscopy in the US from 2015 to 2023. Demographic information, such as age, sex, body mass index (BMI), was analyzed. Prevalence (P), incidence proportion (IP), and incidence rate (IR) were measured. Regression modeling was used to project through 2030. Complications such as femoral neck fracture (FNFx), hemarthrosis, septic arthritis, hip dislocation/instability, avascular necrosis (AVN), osteoarthritis (OA), and conversion to total hip arthroplasty (THA) were also analyzed.</p><p><strong>Results: </strong>In TriNetX, 25,903 patients underwent hip arthroscopy in the US from 2015-2023. In 2023, 2,427 hip arthroscopies occured, a 97% increase compared to 1,236 in 2015. Annual database incidence is projected to rise to over 4,800 cases by 2030. In 2023, prevalence was highest in females aged 20-24, while incidence was highest in females aged 15-19. FNFx, hip dislocation, septic arthritis, and AVN occurred in <1% of patients within 2- and 5-years post-operatively. Males had higher risk for all complications aside from hemarthrosis and trochanteric bursitis which were higher in females at 5 years. 17% developed OA, with 9.8% requiring conversion to THA within 5 years. Majority (>80%) who converted to THA were over the age of 30 at time of hip arthroscopy. There were no sex-based differences in conversion to THA.</p><p><strong>Conclusion: </strong>Our analysis reveals a substantial rise in hip arthroscopy with projections indicating a continued surge. Despite low complication rates, males were found to be at higher risk of most complications aside from hemarthrosis and trochanteric bursitis which were higher in females. The incidence of developing OA and conversion to THA remains significant.</p><p><strong>Level of evidence: </strong>IV (retrospective case series).</p>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":" ","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.arthro.2025.03.034","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: The purpose of this study was to assess hip arthroscopy epidemiology in the United States (US) from 2015-2023 and provide projections through 2030, as well as analyze rates of postoperative complications.
Methods: The TriNetX/U.S. Collaborative Networks database was utilized to identify patients aged 10-89 who underwent hip arthroscopy in the US from 2015 to 2023. Demographic information, such as age, sex, body mass index (BMI), was analyzed. Prevalence (P), incidence proportion (IP), and incidence rate (IR) were measured. Regression modeling was used to project through 2030. Complications such as femoral neck fracture (FNFx), hemarthrosis, septic arthritis, hip dislocation/instability, avascular necrosis (AVN), osteoarthritis (OA), and conversion to total hip arthroplasty (THA) were also analyzed.
Results: In TriNetX, 25,903 patients underwent hip arthroscopy in the US from 2015-2023. In 2023, 2,427 hip arthroscopies occured, a 97% increase compared to 1,236 in 2015. Annual database incidence is projected to rise to over 4,800 cases by 2030. In 2023, prevalence was highest in females aged 20-24, while incidence was highest in females aged 15-19. FNFx, hip dislocation, septic arthritis, and AVN occurred in <1% of patients within 2- and 5-years post-operatively. Males had higher risk for all complications aside from hemarthrosis and trochanteric bursitis which were higher in females at 5 years. 17% developed OA, with 9.8% requiring conversion to THA within 5 years. Majority (>80%) who converted to THA were over the age of 30 at time of hip arthroscopy. There were no sex-based differences in conversion to THA.
Conclusion: Our analysis reveals a substantial rise in hip arthroscopy with projections indicating a continued surge. Despite low complication rates, males were found to be at higher risk of most complications aside from hemarthrosis and trochanteric bursitis which were higher in females. The incidence of developing OA and conversion to THA remains significant.
Level of evidence: IV (retrospective case series).
期刊介绍：
Nowhere is minimally invasive surgery explained better than in Arthroscopy, the leading peer-reviewed journal in the field. Every issue enables you to put into perspective the usefulness of the various emerging arthroscopic techniques. The advantages and disadvantages of these methods -- along with their applications in various situations -- are discussed in relation to their efficiency, efficacy and cost benefit. As a special incentive, paid subscribers also receive access to the journal expanded website.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
